RizaFilm® (rizatriptan) – New drug approval
April 17, 2023 - IntelGenx and Gensco announced the FDA approval of RizaFilm (rizatriptan) oral film, for the acute treatment of migraine with or without aura in adults and in pediatric patients 12 to 17 years of age weighing 40 kg or more.
Download PDF
